Literature DB >> 9291307

Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men.

M E Hagensee1, N Kiviat, C W Critchlow, S E Hawes, J Kuypers, S Holte, D A Galloway.   

Abstract

Human papillomavirus (HPV) has been implicated in the pathogenesis of anal carcinoma, which is increased in homosexual men. Little is known about the serologic response to HPV in normal or immunosuppressed men; therefore, HIV-infected and -uninfected homosexual men were screened for HPV-6 and -16 capsid antibodies. HIV-infected men had increased HPV DNA detection but did not significantly differ in the prevalence of serum HPV antibodies. HPV-6 DNA detection and the presence of anal warts were significantly correlated with serum antibody overall and in the HIV-infected subgroup. HPV-16 DNA detection was not significantly correlated with serum antibody overall or in either subgroup; however, HIV-infected men with high-grade anal squamous intraepithelial lesions were significantly more likely to have HPV-16 antibodies. HIV-infected men are able to generate an antibody response to HPV, and a lack of serum HPV antibodies cannot explain the increased HPV-associated disease seen in HIV-infected men.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291307     DOI: 10.1086/514082

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Serum antibody response following genital {alpha}9 human papillomavirus infection in young men.

Authors:  Zoe R Edelstein; Joseph J Carter; Ruchi Garg; Rachel L Winer; Qinghua Feng; Denise A Galloway; Laura A Koutsky
Journal:  J Infect Dis       Date:  2011-07-15       Impact factor: 5.226

2.  Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in HIV-1-infected men.

Authors:  Timothy Wilkin; Jeannette Y Lee; Shelly Y Lensing; Elizabeth A Stier; Stephen E Goldstone; J Michael Berry; Naomi Jay; David Aboulafia; David L Cohn; Mark H Einstein; Alfred Saah; Ronald T Mitsuyasu; Joel M Palefsky
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

3.  Oral human papillomavirus infection in men might contribute to HPV serology.

Authors:  S Syrjänen; T Waterboer; K Kero; J Rautava; K Syrjänen; S Grenman; M Pawlita
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-14       Impact factor: 3.267

4.  Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study).

Authors:  Beibei Lu; Raphael P Viscidi; Ji-Hyun Lee; Yougui Wu; Luisa L Villa; Eduardo Lazcano-Ponce; Roberto J Carvalho da Silva; Maria Luiza Baggio; Manuel Quiterio; Jorge Salmerón; Danelle C Smith; Martha Abrahamsen; Mary Papenfuss; Heather G Stockwell; Anna R Giuliano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-04       Impact factor: 4.254

5.  Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study.

Authors:  Alan G Nyitray; Roberto J Carvalho da Silva; Maria Luiza Baggio; Beibei Lu; Danélle Smith; Martha Abrahamsen; Mary Papenfuss; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano
Journal:  J Infect Dis       Date:  2011-01-01       Impact factor: 5.226

6.  Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals.

Authors:  Jennifer E Cameron; Isaac V Snowhite; Anil K Chaturvedi; Michael E Hagensee
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

7.  Prevalence and risk factors for neutralizing antibodies to human papillomavirus types 16 and 18 in HIV-positive men who have sex with men.

Authors:  Rachna Sharma; Jimmy T Efird; Aung Chein; Elizabeth A Holly; Mel Krajden; J Michael Berry; Teresa M Darragh; Naomi Jay; Joel M Palefsky
Journal:  J Acquir Immune Defic Syndr       Date:  2013-12-15       Impact factor: 3.731

8.  High prevalence of high risk human papillomavirus-capsid antibodies in human immunodeficiency virus-seropositive men: a serological study.

Authors:  Reinhard Höpfl; Anton Petter; Petra Thaler; Mario Sarcletti; Andreas Widschwendter; Robert Zangerle
Journal:  BMC Infect Dis       Date:  2003-04-30       Impact factor: 3.090

9.  Anal, penile, and oral high-risk HPV infections and HPV seropositivity in HIV-positive and HIV-negative men who have sex with men.

Authors:  Vera M van Rijn; Sofie H Mooij; Madelief Mollers; Peter J F Snijders; Arjen G C L Speksnijder; Audrey J King; Henry J C de Vries; Arne van Eeden; Fiona R M van der Klis; Hester E de Melker; Marianne A B van der Sande; Maarten F Schim van der Loeff
Journal:  PLoS One       Date:  2014-03-20       Impact factor: 3.240

10.  The Prevalence and Genotype Distribution of Human Papillomavirus in the Genital Tract of Males in Iran.

Authors:  Mostafa Salehi-Vaziri; Farzin Sadeghi; Farah Bokharaei-Salim; Sarang Younesi; Samaneh Alinaghi; Seyed Hamidreza Monavari; Hossein Keyvani
Journal:  Jundishapur J Microbiol       Date:  2015-12-18       Impact factor: 0.747

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.